Elias A. Zerhouni

In the mid-1980s, cardiologists faced a particularly vexing problem: how to measure, accurately and noninvasively, the thickness of heart tissue as it changed over time. Elias A. Zerhouni, a young radiology professor at Johns Hopkins School of Medicine, struggled over the issue with a small team of physicists. "One day, he walked into the room with this incredible smile on his face, like you would have if you made a great molecular discovery," recalls Myron Weisfeldt, director of Hopkins' Depart

Written byTed Agres
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Zerhouni and his team had developed a way to tag cardiac tissue, making it visible to noninvasive magnetic resonance imaging (MRI) instruments. The discovery proved to be as practical as it was innovative: The subsequently patented tagging system has become a bedrock MRI technology, used by physiologists, cardiologists, and engineers worldwide.1

"As one of the world's premier experts in magnetic resonance imaging, Elias has extended the role of MRI from taking snapshots of gross anatomy to visualizing how the body works at the molecular level," says Edward D. Miller, dean and CEO, Johns Hopkins University School of Medicine. "In so doing, he has provided a new tool for scientists to understand the origins of disease and how treatments can be tailored to be more effective."

Zerhouni "has displayed a remarkable gift for understanding complex basic science outside his field and appreciating all the ramifications of new findings," adds Solomon H. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies